𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Leiomyoma of the adrenal gland in a patient with AIDS

✍ Scribed by H. Dahan; C. Bèges; L. Weiss; M. Abitbol; O. Ledreff; G. Teman; K. Belattar; R. Rymer

Publisher
Springer
Year
1994
Tongue
English
Weight
644 KB
Volume
19
Category
Article
ISSN
0942-8925

No coin nor oath required. For personal study only.

✦ Synopsis

Leiomyoma of the adrenal gland is an exceptional localization. We report a case occurring in a young patient with AIDS. Diagnosis was a surprise on pathologic examination. On enhanced computed tomographic (CT) scan, the adrenal mass had a low central attenuation area and a thin enhancing peripheral ring. On magnetic resonance (MR) imaging the left adrenal mass was isointense with the liver on T1-(TR/TE = 500/300 ms) and T2-(TR/TE = 2030/60, 120 ms) weighted spin-echo images, except a central area with a lower signal on T1-weighted images and a higher signal on T2-weighted images. The mass was slightly enhanced after Gd-DOTA injection, but the central area remained unchanged.

📜 SIMILAR VOLUMES

Detection of adrenal gland hyperplasia b
Detection of adrenal gland hyperplasia by abdominal ultrasonography in a patient with primary hyperaldosteronism
✍ Cavit Cehreli; Ayşegül Gökçin; Faith R. Toktas; Yahya R. Laleli; Ayşe Saygin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

Primary hyperaldosteronism is a disorder characterized by hypertension associated with an elevated plasma aldosterone concentration on at least one occasion and with a concurrent plasma renin concentration below the mean value. Patients may show symptoms of hypokalemia, such as muscle weakness, pol

Loss of neurofibromin in adrenal gland t
Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I
✍ Dr. David H. Gutmann; Jeffery L. Cole; William J. Stone; Bruce A. J. Ponder; Fra 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

The neurofibromatosis type I gene encodes a protein, neurofibromin, which may function as a tumor suppressor gene product. Recent studies have demonstrated loss of neurofibromin in tumors from NF I and non-NF I patients, including neurofibrosarcomas. neuroblastomas and malignant melanomas. Since ne